![]() |
Name |
Chaephilone E
|
Molecular Formula | C23H31ClO6 | |
IUPAC Name* |
(6aS,8S,9aS)-5-chloro-8-[(2R,3R)-3-hydroxybutan-2-yl]-3-[(E,3R,4R)-4-hydroxy-3-methylpent-1-enyl]-8-methoxy-6a-methyl-9,9a-dihydrofuro[2,3-h]isochromen-6-one
|
|
SMILES |
C[C@H](/C=C/C1=CC2=C(C(=O)[C@@]3([C@H](C2=CO1)C[C@](O3)([C@H](C)[C@@H](C)O)OC)C)Cl)[C@@H](C)O
|
|
InChI |
InChI=1S/C23H31ClO6/c1-12(14(3)25)7-8-16-9-17-18(11-29-16)19-10-23(28-6,13(2)15(4)26)30-22(19,5)21(27)20(17)24/h7-9,11-15,19,25-26H,10H2,1-6H3/b8-7+/t12-,13-,14-,15-,19+,22+,23+/m1/s1
|
|
InChIKey |
JKTQHBZSCNQGSN-RDDZJUFHSA-N
|
|
Synonyms |
Chaephilone E
|
|
CAS | NA | |
PubChem CID | 156582520 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 438.9 | ALogp: | 2.5 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 85.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.642 |
Caco-2 Permeability: | -4.578 | MDCK Permeability: | 0.00001650 |
Pgp-inhibitor: | 0.027 | Pgp-substrate: | 0.714 |
Human Intestinal Absorption (HIA): | 0.021 | 20% Bioavailability (F20%): | 0.186 |
30% Bioavailability (F30%): | 0.983 |
Blood-Brain-Barrier Penetration (BBB): | 0.75 | Plasma Protein Binding (PPB): | 76.66% |
Volume Distribution (VD): | 2.053 | Fu: | 13.74% |
CYP1A2-inhibitor: | 0.459 | CYP1A2-substrate: | 0.781 |
CYP2C19-inhibitor: | 0.335 | CYP2C19-substrate: | 0.842 |
CYP2C9-inhibitor: | 0.4 | CYP2C9-substrate: | 0.033 |
CYP2D6-inhibitor: | 0.657 | CYP2D6-substrate: | 0.047 |
CYP3A4-inhibitor: | 0.921 | CYP3A4-substrate: | 0.845 |
Clearance (CL): | 5.29 | Half-life (T1/2): | 0.256 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.967 |
Drug-inuced Liver Injury (DILI): | 0.812 | AMES Toxicity: | 0.524 |
Rat Oral Acute Toxicity: | 0.928 | Maximum Recommended Daily Dose: | 0.484 |
Skin Sensitization: | 0.881 | Carcinogencity: | 0.936 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.058 |
Respiratory Toxicity: | 0.982 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002777 | ![]() |
0.576 | D03KIA | ![]() |
0.225 | ||
ENC002501 | ![]() |
0.523 | D0G5CF | ![]() |
0.191 | ||
ENC002611 | ![]() |
0.495 | D0C1SF | ![]() |
0.189 | ||
ENC002778 | ![]() |
0.495 | D06JPB | ![]() |
0.185 | ||
ENC002610 | ![]() |
0.495 | D0G8OC | ![]() |
0.185 | ||
ENC005844 | ![]() |
0.467 | D0JE2E | ![]() |
0.175 | ||
ENC005878 | ![]() |
0.467 | D0Z1WA | ![]() |
0.171 | ||
ENC005437 | ![]() |
0.460 | D0L5FY | ![]() |
0.169 | ||
ENC002533 | ![]() |
0.439 | D00BLL | ![]() |
0.165 | ||
ENC002532 | ![]() |
0.412 | D08SVH | ![]() |
0.165 |